title: Benchmark Outcomes for Pulmonary Valve Replacement Using The Society of Thoracic Surgeons Databases.
abstract: BACKGROUND
  As less invasive alternatives to surgical pulmonary valve replacement (PVR) are being refined and evaluated, there is a need for benchmark data concerning outcomes from surgical PVR.
  
  
  METHODS
  We examined in-hospital outcomes from surgical PVR in The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) and Adult Cardiac Surgery Database (STS-ACSD) between 2007 and 2013, with a focus on patients likely to be eligible for transcatheter PVR (ie, ≥ 5 years age and ≥ 30 kg). Patient characteristics, morbidity, and mortality were described.
  
  
  RESULTS
  The STS-CHSD included 6,431 eligible patients with a median age of 17 years (interquartile range [IQR], 14-25 years). Preoperative comorbidities were uncommon: arrhythmia (1.7%), renal failure (0.1%), endocarditis (0.3%), neurologic deficit (0.8%), and diabetes (0.5%). In-hospital mortality was 0.9%. A major complication occurred in 2.2%. The STS-ACSD included 3,352 eligible patients; the median age was 41 years (IQR, 30-55 years). Preoperative comorbidities were more common: arrhythmia (24.3%), renal failure (3.8%), endocarditis (12.2%), cerebrovascular disease (7.9%), and diabetes (10.9%). In-hospital mortality was 4.1%. A major complication occurred in 20.9%.
  
  
  CONCLUSIONS
  Contemporary outcomes from surgical PVR include a low risk of in-hospital death or major complications. Patients in the STS-ACSD are older and have an increased prevalence of preoperative factors, which may contribute to higher morbidity and mortality.
authors.affiliation: Departments of Internal Medicine and Pediatrics, Division of Cardiology, University of Colorado, CU Anschutz, Aurora, Colorado. Electronic address: amber.khanna@ucdenver.edu.
authors.forename: Amber D
authors.initials: AD
authors.lastname: Khanna
authors.affiliation: Department of Pediatrics, Duke Clinical Research Institute, Durham, North Carolina.
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Hill
authors.affiliation: University of Michigan Medical School, Ann Arbor, Michigan.
authors.forename: Sara K
authors.initials: SK
authors.lastname: Pasquali
authors.affiliation: Department of Pediatrics, Duke Clinical Research Institute, Durham, North Carolina.
authors.forename: Amelia S
authors.initials: AS
authors.lastname: Wallace
authors.affiliation: Departments of Internal Medicine and Pediatrics, Division of Cardiology, University of Colorado, CU Anschutz, Aurora, Colorado.
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Masoudi
authors.affiliation: Division of Cardiac Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland.
authors.forename: Marshall L
authors.initials: ML
authors.lastname: Jacobs
authors.affiliation: Division of Cardiac Surgery, Johns Hopkins All Children's Heart Institute, St. Petersburg, Florida.
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Jacobs
authors.affiliation: Division of Pediatric Cardiothoracic Surgery, Benioff Children's Hospital, University of California, San Francisco, San Francisco, California.
authors.forename: Tara
authors.initials: T
authors.lastname: Karamlou
mesh_terms: D000293:Adolescent; D000328:Adult; D019985:Benchmarking; D016208:Databases, Factual; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D011664:Pulmonary Valve / Q000601:surgery*; D012955:Societies, Medical; D013903:Thoracic Surgery; D016896:Treatment Outcome; D055815:Young Adult